2 completed. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
| Phase 2 | 1 | Completed 1 |
Follow Gender Dysphoria: new trials by email Literature Review of Gender Dysphoria trials Research Report on Gender Dysphoria
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluating Drug Interactions Between Doravirine With Estradiol and Spironolactone in Healthy Transgender Women Doravirine/Lamivudine/Tenofovir, Spironolactone 100mg, Estradiol 2mg - Transgender Health, Gender Dysphoria | Phase 1 | Completed | Thomas Jefferson University | 8 | 2022-01-04 | 2025-03-26 |
| Subcutaneous Testosterone Project Subcutaneous testosterone - Gender Dysphoria | Phase 1 / Phase 2 | Completed | University of British Columbia | 14 | 2015-07-01 | 2016-06-06 |
Acquired Immunodeficiency Syndrome (1)
Mental Disorders (2) · Sexual Dysfunctions, Psychological (2) · Blood-Borne Infections (1) · Communicable Diseases (1) · Genital Diseases (1) · HIV Infections (1) · Immune System Diseases (1) · Immunologic Deficiency Syndromes (1) · Infections (1) · Lentivirus Infections (1) · RNA Virus Infections (1) · Retroviridae Infections (1) · Sexually Transmitted Diseases (1) · Sexually Transmitted Diseases, Viral (1) · Slow Virus Diseases (1)
Canrenoic Acid (1) · Estradiol (1) · Spironolactone (1) · doravirine (1) · testosterone 17 beta-cypionate (1)
Thomas Jefferson University (1) · University of British Columbia (1)
Canada (1) · United States (1)
Mary Ensom, Pharm D/PhD (1) · Walter K Kraft, MD (1)